Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 May 10;39(5):1010428317706209. doi: 10.1177/1010428317706209

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — IL-10R expression in CD4⁺ and CD8⁺ T cells in gastric cancer patients and controls. (a) Representative gating of IL-10R-expressing cells in CD4⁺ and CD8⁺ T cells. (b) Frequency of IL-10R-expressing cells as a percentage in CD4⁺ T cells in controls and gastric cancer patients of stages II–IV. (c) Frequency of IL-10R-expressing cells as a percentage in CD8⁺ T cells in controls and gastric cancer patients of stages II–IV. (d) Representative IL-10R expression by IL-10⁺ CD8⁺ T cells versus IL-10⁻ CD8⁺ T cells (left: IL-10 vs IL-10R contour plot in CD8⁺ T cells and right: histogram comparison of IL-10R expression by IL-10⁺ (black unfilled) vs IL-10⁻ (gray filled) CD8⁺ T cells). (e) Differences in IL-10R expression level between IL-10⁺ and IL-10⁻ cells in CD4⁺ and CD8⁺ T cells from healthy controls and gastric cancer patients (*p < 0.05; **p < 0.01; ***p < 0.001).